Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.460
+0.110 (8.15%)
At close: Mar 13, 2026, 4:00 PM EDT
1.473
+0.013 (0.90%)
After-hours: Mar 13, 2026, 7:58 PM EDT
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $94.3 million as of March 13, 2026. Its market cap has decreased by -83.44% in one year.
Market Cap
94.30M
Enterprise Value
117.80M
1-Year Change
-83.44%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $94.30M, a decrease of -89.40%. That is a compound annual growth rate of -36.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 94.06M | -39.75% |
| Dec 31, 2025 | 156.11M | -66.32% |
| Dec 31, 2024 | 463.49M | -41.06% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
| Apr 23, 2021 | 889.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperfine | 114.66M |
| Baird Medical Investment Holdings | 94.75M |
| Neuronetics | 88.35M |
| Xtant Medical Holdings | 87.78M |
| MaxCyte | 86.14M |
| Picard Medical | 84.76M |
| Pulmonx | 75.82M |
| Sera Prognostics | 74.49M |